Biobot Analytics Raises $20m Series A To Expand Virus Detection Work

October 24, 2021

Data exists in unexpected places, waiting to be unlocked by technology. The founders of Biobot Analytics knew wastewater contained information which could be tremendously valuable in understanding and solving public health problems. The first biomarkers they worked on were opioids, helping cities evaluate and direct efforts to measure their impacted populations. Shortly thereafter the team broadened to viruses, rising to the challenge at hand: COVID detection. Now with those successes, the startup has raised an additional $20 million to expand its viral detection to influenza and continue deploying its existing services throughout the country.

The team at Biobot, now 40+ talented folks, is growing quickly so if using sewage to create a new understanding of population health analytics sounds like a mission for you, they’re hiring.